ASTCNasdaqLaboratory Analytical InstrumentsFiscal year ends June 30
ASTROTECH Corp
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$4.75−0.18 (-3.75%)
Close on Oct 19, 2026
- Market cap
- $8.41M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
23.8%+13.0 pts over 5 years
Operating margin
-1548.5%+819.7 pts over 5 years
Net margin
-1580.2%+696.2 pts over 5 years
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -13.0% | +6.8% | +22.3% | -10.2% | |
| Gross profit | -54.3% | -10.8% | +43.2% | -4.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | -51.0% | -24.6% | -75.4% | |
| Return on assets | -46.9% | -21.2% | -60.8% | |
| Current ratio | 7.55 | 15.46 | 7.06 | |
| Inventory turnover | 3.9× | – | – | |
| Capex to revenue | 21.4% | 63.2% | 96.3% | |
| Diluted shares | 0M | 1M | 2M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Astrotech generated $50.55M from operations and spent $4.85M on capital expenditure, dividends and share buybacks. 98% of that went back into the business.
Generated
$50.55M
Used
$4.85M
Capital expenditure$4.73M98%Dividends$00%Share buybacks$119.00K2%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-1580.2%
×Asset turnover0.04×
×Equity multiplier1.24×
=Return on equity, FY2026-75.4%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | -1580.2% | 0.04× | 1.24× | -75.4% |
| FY2025 | -1320.3% | 0.03× | 1.14× | -48.7% |
| FY2024 | -686.2% | 0.04× | 1.07× | -29.3% |
| FY2023 | -1285.6% | 0.01× | 1.06× | -19.7% |
| FY2022 | -958.6% | 0.01× | 1.06× | -14.6% |
| FY2021 | -2276.3% | 0.01× | 1.16× | -24.6% |
| FY2020 | -1703.1% | 0.10× | 2.89× | -498.7% |
| FY2019 | -5932.3% | 0.03× | 1.32× | -224.9% |
| FY2018 | -15408.1% | 0.01× | 1.15× | -127.6% |
| FY2017 | -497.5% | 0.09× | 1.09× | -51.0% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
2of 8 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero-$14.43M
- Cash generatingOperating cash flow above zero-$13.45M
- Return on assets improvedROA up on the prior year-36.8% → -53.5%
- Earnings backed by cashOperating cash flow above net income-$13.45M vs -$14.43M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose8.97 → 7.06
- No dilutionShare count did not rise2M → 2M
- Gross margin improvedGross margin up on the prior year45.28% → 23.77%
- More efficientAsset turnover rose0.03 → 0.03